More recently, it was reported that FAP promotes immunosuppression through upregulation of CCL2, resulting in increased tumor growth by enhancing recruitment of myeloid-derived suppressor cells and tumor-associated macrophages (Yang et al., 2016; Lin et al., 2019). The gene discussed is CCL2; the disease is neoplasm.